NIH-funded research R01 grant

Investigating genetic factors that affect insulin secretion in type 2 diabetes

Official title: Functional Interrogation of Type 2 Diabetes-associated Genetic Network

Funded at Weill Medical Coll of Cornell Univ · NIH-11073518 · Data updated 2026-11-12

This study is looking at how certain genes might affect insulin production in people with type 2 diabetes, using special lab techniques to better understand how these genes impact the cells that make insulin.

More Type 2 Diabetes research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWeill Medical Coll of Cornell Univ
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 19, 2024
Project endJune 30, 2029
Funding year2024
Award (this year)$561,893
NIH project number1R01DK142414-01
Project IDNIH-11073518 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with type 2 diabetes, particularly those with a genetic predisposition to the condition.

Less likely to help

Patients with type 1 diabetes or those without any genetic factors associated with type 2 diabetes may not benefit from this research.

What this research studies

This research focuses on understanding how specific genetic variants contribute to type 2 diabetes by examining their effects on insulin secretion in pancreatic cells. Using advanced techniques like CRISPR and human pluripotent stem cells, the researchers will create models to study the interactions between these genetic factors and their impact on beta cell function. By analyzing how these genes influence insulin production and cell survival, the study aims to uncover the underlying mechanisms of type 2 diabetes.

Why it matters

Potential benefit: If successful, this research could lead to new insights and potential therapies for improving insulin secretion in patients with type 2 diabetes.

How similar studies have gone: Previous research using CRISPR and stem cell technologies has shown promise in understanding genetic contributions to various diseases, suggesting that this approach could yield valuable insights for type 2 diabetes as well.

Where this research is happening

  • Weill Medical Coll of Cornell Univ
    New York, United States
    Active

Researchers

  • Principal investigator: Chen, Shuibing — Weill Medical Coll of Cornell Univ
  • Study coordinator: Chen, Shuibing

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.